Vaxart, Inc. Stockholders Equity

• Vaxart, Inc. showed an increase of +49.0% in Stockholders Equity from 2024 to 2025.
• This data is from Vaxart, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2008 to 2025 (22 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2011: $60.69 million | Q4 2011: $67.39 million | Q1 2012: $59.41 million | Q3 2012: $29.97 million | Q4 2012: $78.96 million | Q1 2013: $80.10 million | Q3 2013: $64.90 million | Q4 2013: $64.20 million | Q1 2014: $96.00 million | Q3 2014: $77.90 million | Q4 2014: $82.40 million | Q1 2015: $81.50 million | Q3 2015: $63.50 million | Q4 2015: $57.50 million | Q1 2016: $52.70 million | Q3 2016: $36.60 million | Q1 2017: $24.20 million | Q2 2017: $18.70 million | Q3 2017: $13.90 million | Q1 2018: $31.11 million | Q2 2018: $22.35 million | Q3 2018: $15.99 million | Q1 2019: $12.58 million | Q2 2019: $15.85 million | Q3 2019: $18.90 million | Q1 2020: $31.29 million | Q2 2020: $40.24 million | Q3 2020: $131.68 million | Q1 2021: $176.24 million | Q2 2021: $199.78 million | Q3 2021: $204.95 million | Q1 2022: $166.37 million | Q2 2022: $143.09 million | Q3 2022: $122.31 million | Q1 2023: $89.75 million | Q2 2023: $85.07 million | Q3 2023: $71.52 million | Q1 2024: $55.69 million | Q2 2024: $80.01 million | Q3 2024: $68.44 million | Q1 2025: $45.62 million | Q2 2025: $32.88 million | Q3 2025: $26.76 million.
• Over the full 22 years of available data (2008 to 2025), Vaxart, Inc.'s Stockholders Equity has declined by 27.7%.
• Historical annual values: Fiscal year 2025: $87.80 million | Fiscal year 2024: $58.93 million | Fiscal year 2023: $57.81 million | Fiscal year 2022: $110.60 million | Fiscal year 2021: $187.53 million | Fiscal year 2020: $123.40 million | Fiscal year 2019: $12.95 million | Fiscal year 2018: $11.21 million | Fiscal year 2017: -$38.72 million | Fiscal year 2017: $18.70 million | Fiscal year 2016: -$29.64 million | Fiscal year 2016: $46.20 million | Fiscal year 2015: $69.50 million | Fiscal year 2014: $86.90 million | Fiscal year 2013: $68.00 million | Fiscal year 2012: $59.30 million | Fiscal year 2011: $58.87 million | Fiscal year 2011: $81.40 million | Fiscal year 2010: $60.57 million | Fiscal year 2010: $87.40 million | Fiscal year 2009: $97.41 million | Fiscal year 2008: $121.38 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026